Patacchini R, Santicioli P, Maggi C A
Pharmacology Department, Research Laboratory, Florence, Italy.
J Auton Pharmacol. 1997 Dec;17(6):345-51. doi: 10.1046/j.1365-2680.1997.00470.x.
1 This study aimed to assess the effect of cyclopiazonic acid (CPA), an inhibitor of sarcoplasmic reticulum calcium (Ca) pump, against contractile responses produced by selective tachykinin NK1 and NK2 receptor agonists, [Sar9]substance P (SP) sulfone and [beta Ala8]neurokinin A (NKA) (4-10), respectively, on the circular muscle of guinea-pig colon. All experiments were performed in the presence of atropine (1 microM) and indomethacin (10 microM). 2 In organ bath experiments, a submaximally equieffective concentration of the two agonists (10 nM) was selected: [Sar9]SP sulfone (10 nM) produced a biphasic contraction, the two amplitudes averaging 75 +/- 2 and 43 +/- 3% of the maximal response to KCl (80 mM) at 1 and 15 min from application of the agonist, respectively. CPA (3 microM for 60 min) slightly reduced the phasic response to [Sar9]SP sulfone (16 +/- 4% inhibition) and markedly suppressed the tonic component (89 +/- 3% inhibition). 3 The contraction produced by [beta Ala8]NKA (4-10) (10 nM) was more sustained than that induced by the NK1 receptor agonist: it averaged 69 +/- 5 and 73 +/- 4% of the response to KCl at 1 and 15 min from application of the agonist, respectively. CPA slightly and evenly depressed the response to [beta Ala8]NKA (4-10) (18 +/- 7 and 21 +/- 5% inhibition at 1 and 15 min). 4 In the presence of tachykinin NK1 and NK2 receptor antagonists (SR 140333 and MEN 10627, respectively, 1 microM each) and of L-nitroarginine (100 microM), KCl (40 mM) produced a distinct phasic and tonic contraction which was suppressed by 1 mM nifedipine. CPA (3 microM) did not affect the phasic contraction to KCl but abolished the tonic component of the response. 5 In the presence of 1 microM nifedipine, the response to [beta Ala8]NKA (4-10) was slightly depressed (32 +/- 6% inhibition) in its early component only, while the response to [Sar9]SP sulfone was abolished. CPA produced a slight inhibition (15 +/- 9 and 33 +/- 10% at 1 and 15 min, respectively) of the nifedipine-resistant response to [beta Ala8]NKA (4-10), an effect similar to that observed in the absence of nifedipine. Therefore, a large part of the response to [beta Ala8]NKA (4-10) persisted in the presence of both CPA and nifedipine. 6 In the sucrose gap, a prolonged superfusion with [Sar9]SP sulfone (0.1 microM for 5 min) produced sustained depolarization with superimposed spikes and contraction. CPA (3 microM) produced transient depolarization and contraction. In the presence of CPA, the initial responses (depolarization, spikes and contraction) to [Sar9]SP sulfone were unaffected but the sustained component of contraction was absent; the latter effect was accompanied by a suppression of spikes while the sustained depolarization was present. 7 We conclude that, during sustained depolarization produced by the NK1 receptor agonist, blockade of the sarcoplasmic reticulum Ca pump by CPA produces a faster Ca-dependent inactivation of Ca channels, thereby eliminating spikes and abolishing the tonic component of contraction. Ca mobilization/reuptake from a CPA-sensitive store seems to be of minor importance for regulating the NK2 receptor-mediated contractile responses.
1 本研究旨在评估肌浆网钙泵抑制剂环匹阿尼酸(CPA)对豚鼠结肠环行肌由选择性速激肽NK1和NK2受体激动剂,即[Sar9]P物质(SP)砜和[β丙氨酸8]神经激肽A(NKA)(4 - 10)分别产生的收缩反应的影响。所有实验均在阿托品(1微摩尔)和吲哚美辛(10微摩尔)存在的情况下进行。2 在器官浴实验中,选择两种激动剂的亚最大等效浓度(10纳摩尔):[Sar9]SP砜(10纳摩尔)产生双相收缩,在施加激动剂后1分钟和15分钟时,两个幅度分别平均为对氯化钾(80毫摩尔)最大反应的75±2%和43±3%。CPA(3微摩尔,作用60分钟)轻微降低了对[Sar9]SP砜的相性反应(抑制16±4%),并显著抑制了紧张性成分(抑制89±3%)。3 [β丙氨酸8]NKA(4 - 10)(10纳摩尔)产生的收缩比NK1受体激动剂诱导的收缩更持久:在施加激动剂后1分钟和15分钟时,它分别平均为对氯化钾反应的69±5%和73±4%。CPA轻微且均匀地抑制了对[β丙氨酸8]NKA(4 - 10)的反应(在1分钟和15分钟时分别抑制18±7%和21±5%)。4 在速激肽NK1和NK2受体拮抗剂(分别为SR 140333和MEN 10627,各1微摩尔)以及L - 硝基精氨酸(100微摩尔)存在的情况下,氯化钾(40毫摩尔)产生明显的相性和紧张性收缩,并被1毫摩尔硝苯地平抑制。CPA(3微摩尔)不影响对氯化钾的相性收缩,但消除了反应的紧张性成分。5 在1微摩尔硝苯地平存在的情况下,对[β丙氨酸8]NKA(4 - 10)的反应仅在其早期成分中轻微受抑制(抑制32±6%),而对[Sar9]SP砜的反应则被消除。CPA对[β丙氨酸8]NKA(4 - 10)的硝苯地平抗性反应产生轻微抑制(在1分钟和15分钟时分别为15±9%和33±10%),这一效应与在无硝苯地平情况下观察到的相似。因此,在CPA和硝苯地平同时存在的情况下,对[β丙氨酸8]NKA(4 - 10)的大部分反应仍然存在。6 在蔗糖间隙实验中,用[Sar9]SP砜(终浓度0.1微摩尔,持续5分钟)长时间灌流产生持续去极化,并伴有叠加的锋电位和收缩。CPA(3微摩尔)产生短暂去极化和收缩。在CPA存在的情况下,对[Sar9]SP砜的初始反应(去极化、锋电位和收缩)未受影响,但收缩的持续成分消失;后一效应伴随着锋电位的抑制,而持续去极化仍然存在。7 我们得出结论,在NK1受体激动剂产生的持续去极化过程中,CPA对肌浆网钙泵的阻断导致钙通道更快地依赖钙失活,从而消除锋电位并消除收缩的紧张性成分。从CPA敏感储存库中动员/再摄取钙对于调节NK2受体介导的收缩反应似乎不太重要。